• EL - ελληνικά
  • EN - English
Parliamentary question - E-000074/2023Parliamentary question

Shortage of medicines

Question for written answer  E-000074/2023
to the Commission
Rule 138
Maria Spyraki (PPE)

Shortages of medicines in Europe owing to interruptions or reductions in the production and supply of the necessary raw materials from China and India have been exacerbated by an early wave of influenza[1][2].

Price increases for hitherto cheap pharmaceutical products are being envisaged as a possible means of combating global shortages, provided that patients do not bear the brunt of such a measure.

Given the disastrous impact of these growing shortages on patients in the EU:

Submitted: 11.1.2023

Last updated: 17 January 2023
Legal notice - Privacy policy